Mu Tong - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mu Tong

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Cancer Cell International|December 9, 2020

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancerQin Xie, Ying-Sheng Xiao, Shi-Cheng Jia, et al.

BMC Infectious Diseases|September 29, 2021

Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, ChinaMu-Tong Fang, You-Feng Su, Hui-Ru An, et al.

Frontiers in Oncology|September 16, 2021

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast CancerYuan-Ke Liang, Ze-Kun- Deng, Mu-Tong Chen, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Cancer Cell International|December 9, 2020

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancerQin Xie, Ying-Sheng Xiao, Shi-Cheng Jia, et al.

BMC Infectious Diseases|September 29, 2021

Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, ChinaMu-Tong Fang, You-Feng Su, Hui-Ru An, et al.

Frontiers in Oncology|September 16, 2021

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast CancerYuan-Ke Liang, Ze-Kun- Deng, Mu-Tong Chen, et al.

Pageof 3